Approximately 80% of the changes in primary GBM are connected with the CDKN2A/p16-CDK4/6-RB pathway, with CDKN2A gene deletion or mutation, CDK4 amplification, and RB1 mutation or deletion being the most common causes [39]. The gene discussed is CDKN2A; the disease is glioblastoma.